Assessing venous thromboembolism risk in lung cancer: a comprehensive evaluation of the khorana score, clinical characteristics, and incidence of thrombosis

IntroductionVenous thromboembolism (VTE) occurrence in patients with lung cancer is associated with significant morbidity and mortality. The Khorana Score (KRS) is a validated risk stratification tool developed to estimate risk of VTE in patients with cancer that incorporates clinical and laboratory...

Повний опис

Бібліографічні деталі

Автори:	Sean C. Dougherty, Rishika Singh, Caleb McKinney, Aditya Singh, Jack Masur, Alia C. Lynch, Ryan D. Gentzler, Wendy Novicoff, Nathan Roberts, Richard D. Hall
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Frontiers Media S.A. 2026-01-01
Серія:	Frontiers in Oncology
Предмети:	khorana risk score non-small cell lung cancer oncogenic driver mutation small cell lung cancer venous thromboembolism
Онлайн доступ:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1651192/full
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!